{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:24:38Z","timestamp":1777440278230,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.atherosclerosis.2015.04.804","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T13:30:18Z","timestamp":1430055018000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population"],"prefix":"10.1016","volume":"241","author":[{"given":"Eiji","family":"Oda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00592-011-0309-6","article-title":"Metabolic syndrome: its history, mechanisms, and limitations","volume":"49","author":"Oda","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","article-title":"Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance","volume":"46","author":"Iwasaki","year":"2007","journal-title":"Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2459\/JCM.0b013e3283627700","article-title":"Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults","volume":"15","author":"Vallianou","year":"2014","journal-title":"J.\u00a0Cardiovasc Med. (Hagerstown)"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabres.2005.08.009","article-title":"Serum cholinesterase activity in diabetes and associated pathologies","volume":"72","author":"In\u00e1cio Lunkes","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-9120(75)91072-3","article-title":"Relationship between serum cholinesterase and low density lipoproteins in children with nephrotic syndrome","volume":"8","author":"Way","year":"1975","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jcp.18.6.811","article-title":"Pseudocholinesterase activity in thyroid disease","volume":"18","author":"Thompson","year":"1965","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(78)90100-6","article-title":"Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients","volume":"85","author":"Chu","year":"1978","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0009-8981(76)90093-0","article-title":"Increased serum gamma-glutamyltransferase in hypertriglyceridemia: comparison with serum pseudocholinesterase","volume":"71","author":"Cucuianu","year":"1976","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1373\/clinchem.2005.059857","article-title":"Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem","volume":"52","author":"Calderon-Margalit","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib10","first-page":"71","article-title":"Serum pseudocholinesterase activity during experimental fattening","volume":"14","author":"Popescu","year":"1976","journal-title":"Med. Interne"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/BF01989883","article-title":"Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice","volume":"37","author":"Kutty","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tvjl.2009.07.030","article-title":"Relationship between serum butyrylcholinesterase and obesity in dogs: a preliminary report","volume":"186","author":"Tvarijonaviciute","year":"2010","journal-title":"Vet. J."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib13","doi-asserted-by":"crossref","unstructured":"Oda E. Serum cholinesterase is inversely associated with body weight change in men undergoing routine health screening. Intern Med. 2015 (in press).","DOI":"10.2169\/internalmedicine.54.4335"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cen.12171","article-title":"Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai healthcare Study","volume":"80","author":"Sato","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib15","first-page":"p33","article-title":"Chapter 3 in Japan atherosclerosis society guidelines for prevention of atherosclerotic cardiovascular diseases 2012","author":"Japan Atherosclerosis Society","year":"2012","journal-title":"Kyorinsha"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000154021","article-title":"The C5 isozyme of serum cholinesterase and adult weight","volume":"41","author":"Chautard-Freire-Maia","year":"1991","journal-title":"Hum. Hered."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1353\/hub.2001.0047","article-title":"Association of the CHE2 locus with body mass index and butyrylcholinesterase activity","volume":"73","author":"Alc\u00e2ntara","year":"2001","journal-title":"Hum. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.ijo.0802464","article-title":"Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5- phenotypes","volume":"27","author":"Alc\u00e2ntara","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S1415-47572011000200006","article-title":"Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes","volume":"34","author":"Dantas","year":"2011","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gene.2013.08.068","article-title":"1914G variant of BCHE gene associated with enzyme activity, obesity and triglyceride levels","volume":"532","author":"Lima","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbi.2008.03.009","article-title":"The butyrylcholinesterase knockout mouse is obese on a high-fat diet","volume":"175","author":"Li","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.atherosclerosis.2015.04.804_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2014.12.009","article-title":"Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population","author":"Bono","year":"2015","journal-title":"Neurochem. Int."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015010229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015010229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T05:24:13Z","timestamp":1537680253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015010229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0021915015010229"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.804","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}